Rare Adverse Thrombotic Events After ChAdOx1 nCov-19 Vaccination
To better understand the development of a rare clotting, investigators conducted a PF4-heparin ELISA and a PF4 ELISA to identify platelet-activating antibodies.
Rita Aghjayan
Assistant Editor
Rita Aghjayan is assistant editor for The Clinical Advisor. She holds a BS in biology with minors in physics and chemistry from Pace University in New York. Prior to joining Haymarket, Rita conducted research both in quantum physics and microbial ecology.
